Bispecific Drugs for Cancers
Exhibitor: CENTER FOR BIOMEDICAL RESEARCH AND DEVELOPMENT
Booth No: N416
Characteristic
The existing drugs for glioblastoma and pancreatic cancer cannot effectively improve the overall survival rate of patients. We have successfully developed bispecific drugs targeting integrins and VEGFR2 pathways that can significantly reduce tumor growth and increase the survival rate. Our animal analyses showed that they are effective protein drugs for the treatments of glioblastoma and pancreatic cancer.
Other Products
-
Antithrombotic Drug with Low Risk of Bleeding
-
Fibrin and Platelet-targeting Thrombolytic Drug
-
Anti-fibrotic Drug Targeting ECM
-
Modification Platforms for Protein Therapeutics
-
Protein Production and GLP Laboratory
Highest Rated Products
-
WINMAPᵀᴹ
-
DS MAPs
-
WINMAP™ Mini
-
Power Patch
-
V Patch
-
Vaccine Microarray Patches
-
Pneumatic Liquid Filling Machine
-
Powder Machine-High Speed Mixer / Granulator
-
Planetary Vacuum Mixer
-
SEMI-AUTOMATIC EYESHADOW PRESS MACHINE
-
2ton Mixing and Melting Tank with Storage Tanks
-
High Speed Mixing Machine
-
In-Line Homogenizer
-
VACUUM EMULSIFY MIXING EQUIPMENT (Bottom Homogenized Series)
-
VACUUM EMULSIFY MIXING EQUIPMENT
-
VACUUM EMULSIFY MIXING EQUIPMENT
-
UV-Visible Spectrophotometer
-
Cell Function Assay Kit(Apoptosis/Cycle/Proliferation/Cytotoxicity/Viability)
-
Biostatistical Analysis
-
Data Management
-
CM30 Incubation Monitoring System
-
CURIOSIS Celloger Nano
-
CDMO services
-
DISCOVERY Comfort Pipettor
-
LTS Style Pipette Tips
-
Rotary Evaporator
-
Centrifugal Evaporator (Teflon coated)
-
Clinical Small Centrifuges
-
High Performance Liquid Chromatography, HPLC
-
Risk Assessment
